Aktia Bank Plc
15.1.2021 09:02:00 CET | Globenewswire | Press release
Aktia Bank Plc
Stock Exchange Release
15 January 2021 at 10.00 a.m.
Correction: Change in the number of own shares held by Aktia Bank Plc
This release replaces the stock exchange release published by Aktia Bank Plc on 4 January 2021 at 3.00 p.m., which incorrectly stated that the number of own shares held by the company was 83,893.
Aktia Bank Plc has on 4 January 2021, supported by a decision taken by the company's Board of Directors, divested 29,595 own shares held by the company for payment of deferred instalments for the earning periods 2016–2017, 2017–2018, 2018–2019 and other incentive programmes to a total of 21 persons.
Following the divestment and the return of shares the company holds 83,777 own shares.
Aktia Bank Plc
Further information:
Outi Henriksson, CFO, tel. +358 10 247 6236
Distribution:
Nasdaq Helsinki Ltd
Mass media
www.aktia.com
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
CGTN19.9.2026 08:41:28 CEST | Press release
CGTN:CGTN Poll | Why is the SCO Solution for Global Governance Drawing Wide Attention?
Teva Pharmaceutical Industries Ltd18.9.2026 22:32:00 CEST | Press release
New Teva Study Identifies the Attributes that Healthcare Providers Prioritize when Selecting a Treatment for Tardive Dyskinesia in Older Patients
Teva Pharmaceutical Industries Ltd18.9.2026 22:31:00 CEST | Press release
Teva Highlights New Real-World Data Showing UZEDY® (risperidone) Outperforms Other Long-Acting Injectables in Keeping Schizophrenia Patients on Treatment, While Reducing Emergency Care and Healthcare Costs
Teva Pharmaceutical Industries Ltd18.9.2026 22:30:00 CEST | Press release
Teva Announces New Olanzapine LAI (TEV-'749) Post Hoc Data Highlighting High Rates of Stabilization and Long-Term Efficacy as Once-Monthly Subcutaneous Injectable for the Treatment of Schizophrenia in Adults
Leading Edge Materials Corp.18.9.2026 20:30:00 CEST | Press release
LEADING EDGE MATERIALS REPORTS QUARTERLY RESULTS TO JULY 31, 2026 AND ANNOUNCES CLOSING OF THE SECOND TRANCHE OF PRIVATE PLACEMENT
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
